Stanley-Laman Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,946	Closed	-$313K	–	264
2018 Q1	$313K	Sell	13,946 -287,159	-95%	-$6.44M	0.07%	236
2017 Q4	$9.07M	Buy	301,105 +157,229	+109%	+$4.73M	1.96%	1
2017 Q3	$5.42M	Buy	+143,876	New	+$5.42M	1.45%	14